Clinical Trials Browser

Phase 2 × avelumab × Endocrine × Clear all

NCT04291885 2025-04-03

I-MAT

Phase 2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03278379 2024-12-24

NET-002

Phase 2 Completed

Neuroendocrine Tumors

NCT03352934 2022-02-25

AveNEC

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03147404 2019-12-30

MS100070-0177

Phase 2 Completed

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine